Using histone deacetylase (HDAC) inhibitors in the FUS-ALS models can influence cytoplasmic localization of FUS, promote the acetylation of FUS RNA binding domain (RRM) and change its interaction with RNA. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.